Factors influencing residual nodal burden in patients with node positive breast cancer treated with neoadjuvant chemotherapy with residual node positive disease enrolled on Alliance A011202 clinical trial
   Google Scholar   
Citation:
Meeting Instance:
SABCS 2024
Year:
2024
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180868 (NRG Oncology); U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                             
Networks:
LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-TX035, NE003, NY167   
Study
Alliance-A011202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: